# FDA Warning Letter: Azurity Pharmaceuticals, Inc.
> 2024-09-24 · Center for Drug Evaluation and Research (CDER) · `f918da8db005d3bc`
## Letter
- **Company:** Azurity Pharmaceuticals, Inc.
- **Posted Date:** 2024-09-24
- **Letter Issue Date:** 2024-09-20
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*